Literature DB >> 11234724

A model for predicting the future incidence of coronary heart disease within percentiles of coronary heart disease risk.

J J McNeil1, A Peeters, D Liew, S Lim, T Vos.   

Abstract

BACKGROUND: We present a method (The CHD Prevention Model) for modelling the incidence of fatal and nonfatal coronary heart disease (CHD) within various CHD risk percentiles of an adult population. The model provides a relatively simple tool for lifetime risk prediction for subgroups within a population. It allows an estimation of the absolute primary CHD risk in different populations and will help identify subgroups of the adult population where primary CHD prevention is most appropriate and cost-effective.
METHODS: The CHD risk distribution within the Australian population was modelled, based on the prevalence of CHD risk, individual estimates of integrated CHD risk, and current CHD mortality rates. Predicted incidence of first fatal and nonfatal myocardial infarction within CHD risk strata of the Australian population was determined.
RESULTS: Approximately 25% of CHD deaths were predicted to occur amongst those in the top 10 percentiles of integrated CHD risk, regardless of age group or gender. It was found that while all causes survival did not differ markedly between percentiles of CHD risk before the ages of around 50-60, event-free survival began visibly to differ about 5 years earlier.
CONCLUSIONS: The CHD Prevention Model provides a means of predicting future CHD incidence amongst various strata of integrated CHD risk within an adult population. It has significant application both in individual risk counselling and in the identification of subgroups of the population where drug therapy to reduce CHD risk is most cost-effective.

Entities:  

Mesh:

Year:  2001        PMID: 11234724     DOI: 10.1177/174182670100800105

Source DB:  PubMed          Journal:  J Cardiovasc Risk        ISSN: 1350-6277


  8 in total

1.  The effect of modifiable risk factors on geographic mortality differentials: a modelling study.

Authors:  Christopher E Stevenson; Haider Mannan; Anna Peeters; Helen Walls; Dianna J Magliano; Jonathan E Shaw; John J McNeil
Journal:  BMC Public Health       Date:  2012-01-25       Impact factor: 3.295

2.  Predicting the effectiveness of prevention: a role for epidemiological modeling.

Authors:  Helen L Walls; Anna Peeters; Christopher M Reid; Danny Liew; John J McNeil
Journal:  J Prim Prev       Date:  2008-07

3.  Absolute risk representation in cardiovascular disease prevention: comprehension and preferences of health care consumers and general practitioners involved in a focus group study.

Authors:  Sophie Hill; Janet Spink; Dominique Cadilhac; Adrian Edwards; Caroline Kaufman; Sophie Rogers; Rebecca Ryan; Andrew Tonkin
Journal:  BMC Public Health       Date:  2010-03-04       Impact factor: 3.295

Review 4.  Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature.

Authors:  David Epstein; Leticia García-Mochón; Stephen Kaptoge; Simon G Thompson
Journal:  Eur J Health Econ       Date:  2015-12-18

5.  Reduced Left Ventricular Ejection Fraction Is a Risk Factor for In-Hospital Mortality in Patients after Percutaneous Coronary Intervention: A Hospital-Based Survey.

Authors:  Ziliang Ye; Haili Lu; Lang Li
Journal:  Biomed Res Int       Date:  2018-12-05       Impact factor: 3.411

6.  Predictors for independent external validation of cardiovascular risk clinical prediction rules: Cox proportional hazards regression analyses.

Authors:  Jong-Wook Ban; Richard Stevens; Rafael Perera
Journal:  Diagn Progn Res       Date:  2018-02-06

7.  Differences in primary health care delivery to Australia's Indigenous population: a template for use in economic evaluations.

Authors:  Katherine S Ong; Rob Carter; Margaret Kelaher; Ian Anderson
Journal:  BMC Health Serv Res       Date:  2012-09-07       Impact factor: 2.655

8.  Improvements in life expectancy among Australians due to reductions in smoking: Results from a risk percentiles approach.

Authors:  Haider Mannan; Andrea J Curtis; Andrew Forbes; Dianna J Magliano; Judy A Lowthian; Manoj Gambhir; John J McNeil
Journal:  BMC Public Health       Date:  2016-01-26       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.